Phase II study of troxacitabine (BCH-4556) in patients with advanced non-small-cell lung cancer.
Dent SF, Arnold A, Stewart DJ, Gertler S, Ayoub J, Batist G, Goss G, Nevile A, Soulieres D, Jolivet J, McLntosh L, Seymour L.
Dent SF, et al. Among authors: jolivet j.
Lung. 2005 Jul-Aug;183(4):265-72. doi: 10.1007/s00408-004-2539-7.
Lung. 2005.
PMID: 16211462
Clinical Trial.